MarketReportsOnline.com adds "Global Alpha 1-Antitrypsin (AAT) Replacement Therapy Market: Size, Trends and Forecast (2016-2020)" report to its research store.
Pune, Maharashtra -- (SBWIRE) -- 12/19/2016 -- The report titled "Global Alpha 1-Antitrypsin (AAT) Replacement Therapy Market" provides an in-depth analysis of the global AAT Replacement Therapy market with detailed analysis of market sizing, growth and market share. The report provides market size by value and volume along with the supply trend prevailing in the market.
Purchase a copy of this research report at http://www.marketreportsonline.com/contacts/purchase.php?name=555500.
The report provides detail market analysis of the major products available in the market for treating AAT deficiency. The four major products included are, Prolastin, Glassia, Zemaira, and Aralast. Among which, Prolastin had the monopoly in the market for over 25 years, Asit was the first AAT Replacement Therapy available in the market for the treatement.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global AAT Replacement Therapy market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition in the global AAT Replacement Therapy market is stiff and dominated by the big players like Grifols. Further, key players of the AAT Replacement Therapy market, Kamada, Shire and CSL Behring are also profiled with their financial information and respective business strategies.
Regional Coverage: Global
- Grifols SA
- Kamada Ltd.
- CSL Behring LLC
- Shire PLC?
Alpha 1 antitrypsin is a type of plasma protein inside our body, it is called protease inhibitor. AAT is made in the liver and its function is to protect lungs and liver. Deficiency of AAT protein is caused by genetic defect. Adults with severe AAT deficiency develop emphysema. Smoking can increase the risk of emphysema. The market to replace AAT deficiency by replacement therapy has grown with in past 5-10 years.
The global AAT Replacement therapy market has increased at a significant CAGR during the span of 4 years i.e. 2012-2015 and projections are made that the market would rise in the next five years i.e. 2016-2020 tremendously. The market for AAT replacement therapy has increased significantly in these years because the people as well as doctors have become more aware of the disease. Earlier, patients suffering from AAT deficiency were treated like asthma patients or other COPD patients. But, now, doctors have access to better diagnostics tests that can detect disease at the early stage.
Complete report available at http://www.marketreportsonline.com/555500.html.
Improvement in the method of treatment is the major driver for the growth of the market, a number of technologies and diagnostics have been innovated to treat and diagnose the same. Thus, the increased awareness along with improved treatment signifies the upsurge in the AAT Replacement Therapy market. Also, the number the of prescriptions for AAT Replacement therapy have been reported to increase at an increasing rate, driving the market in the positive direction. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as: the cost of the treatment is high for people, limited plasma fraction capacity and side-effects of alpha1 proteinase inhibitor.
Few Points from List of Tables & Figures:
List of Tables
Table 1: AAT Replacement Therapy Products
Table 2: Global AAT Replacement Therapy Market Major Players
Table 3: Shire Research and Development Expenditure; 2015 (US$ Million)
List of Figures
Figure 1: Global AAT Replacement Therapy Market by Value; 2012-2015 (US$ Million)
Figure 2: Global AAT Replacement Therapy Market by Value; 2016E-2020E (US$ Billion)
Figure 3: Global AAT Replacement Therapy Market by Volume; 2012-2015 (Thousand)
Figure 4: Global AAT Replacement Therapy Market by Volume; 2016E-2020E (Thousand)
Figure5: Global AAT Replacement Therapy by Product; 2015 (%)
Figure 6: Global Prolastin AAT Replacement Therapy Market by Value; 2013-2015 (US$ Million)
Figure 7: Global Zemaira AAT Replacement Therapy Market by Value; 2013-2015E (US$ Million)
Figure 8: Global Glassia AAT Replacement Therapy Market by Value; 2011-2015 (US$ Million)
Figure 9: The U.S. Glassia AAT Replacement Therapy Prescriptions; 2010-2016E
Figure 10: Global Aralast AAT Replacement Therapy Market by Value; 2014-2015 (US$ Million)
Explore more pharmaceuticals market research as well as other newly published reports by Daedal Research at http://www.marketreportsonline.com/publisher/daedal-research-market-research.html.
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
2nd Floor, Metropole, Next to Inox Theatre, Bund Garden Road, Pune - 411001. Maharashtra, India.